The UK and Europe should do more to attract investment from the pharmaceutical industry to prevent companies going elsewhere, a top AstraZeneca has said.
The region needs to look at speeding up regulation when it comes to authorising new medicines and create greater incentives for innovation, the company’s Global Head of Operations and IT Pam Cheng said on Wednesday in an interview at the Bloomberg New Economy Gateway Europe Forum, which is being held at ...
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: